Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Efficacy of Inhaled GSK159797 (Milveterol) in Asthma
NCT00354666Phase 2Completed
- Sponsor
- GSK
- Start
- Sep 2004
- Modality
- Orthosteric Ligands
01
Overview
Phase 2, randomised, double-blind trial in asthma comparing GSK159797 with Placebo (2 arms). Primary endpoint: Safety and tolerability including blood test results, effects on the heart, pulse rate and blood pressure, and side effects. Started Sep 2004; status: completed.
02
Drugs
milveterol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00354666.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00354666.